Cancer BiologybioRxivPreprint
Chryseobacterium indologenes mediates resistance to osimertinib by activating the IGF1R pathway in EGFR-mutant lung adenocarcinoma
DOI 10.1101/2025.10.08.681060
Author
Weizmann Institute of ScienceORCID 0000-0001-6091-5470Unclaimed ORCID profile · follow to get notified of new preprints
1 paper
Recent·Most cited